The Estimation of Thyroid Cancer Risk based on Type 2 Diabetes Mellitus and ABO Blood Group
Yıl: 2020 Cilt: 35 Sayı: 1 Sayfa Aralığı: 64 - 69 Metin Dili: İngilizce DOI: 10.5505/tjo.2020.2066 İndeks Tarihi: 04-12-2020
The Estimation of Thyroid Cancer Risk based on Type 2 Diabetes Mellitus and ABO Blood Group
Öz: OBJECTIVEMultiple potential risk factors have been proposed for the development of thyroid cancer. Type 2 diabetes and ABO blood group had a significant relationship with some cancers. These agents may be relatedto thyroid cancer. This study investigates the association between thyroid cancer and diabetes and theABO blood group.METHODSThis analytic study was conducted in patients with thyroid cancer (n=87) and the individuals cancerfree (n=929). The odds ratio of thyroid cancer was estimated in diabetic patients after adjusting age andsex. The distribution of the blood groups in both groups was determined and compared with considering confidence interval 95%.RESULTSWe observed a significant association between thyroid cancer and type 2 diabetes (odds ratio (OR): 4.42,95% confidence interval (CI): 2.04-9.57, p<0.001). There was a significantly lower frequency of bloodtype A in patients with thyroid cancer (25.3%) compared to the control group (34.4%) with a reducedrisk of 43% (OR: 0.57; 95% CI: 0.33–0.97, p=0.04 ). The patients with blood type B had a borderline riskof thyroid cancer (OR: 1.60, 95% CI: 0.96–2.70, p=0.07).CONCLUSIONOur findings show the relationship between type 2 diabetes and thyroid cancer. The blood type A cansignificantly decrease the risk of thyroid cancer, and the blood type B may increase. To confirm theseresults, further studies should be conducted.
Anahtar Kelime: Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
- 1. Shih SR, Chiu WY, Chang TC, Tseng CH. Diabetes and thyroid cancer risk: literature review. Exp Diabetes Res 2012;2012:578285.
- 2. Esteghamati A, Larijani B, Aghajani MH, Ghaemi F, Kermanchi J, Shahrami A, et al. Diabetes in Iran: prospective analysis from first nationwide diabetes report of National Program for Prevention and Control of Diabetes (NPPCD-2016). Sci Rep 2017;7(1):13461.
- 3. Noto H, Tsujimoto T, Sasazuki T, Noda M. Significantly increased risk of cancer in patients with diabetes mellitus: a systematic review and meta-analysis. Endocr Pract 2011;17(4):616−28.
- 4. Chen Y, Zhu C, Chen Y, Wang N, Li Q, Han B, et al. The Association of Thyroid Nodules with Metabolic Status: A Cross-Sectional SPECT-China Study. Int J Endocrinol 2018;2018:6853617.
- 5. Mansour A, Mohammed MA, Anwar R, Elzafrany M, Omar NM. AB0 blood group and risk of malignancies in Egyptians. Int J Cancer Res 2014;10(2):81−95.
- 6. Tam AA, Özdemir D, Fakı S, Bilginer MC, Ersoy R, Çakır B.ABO Blood Groups, Rh Factor, and Thyroid Cancer Risk: To ‘B’ or Not to ‘B’. Endocr Res. 2019 Nov 25:1-10. doi: 10.1080/07435800.2019.1695261. [Epub ahead of print]
- 7. Gong Y, Yang YS, Zhang XM, Su M, Wang J, Han JD, et al. ABO blood type, diabetes and risk of gastrointestinal cancer in northern China. World J Gastroenterol 2012;18(6):563−9.
- 8. Hemminki K, Li X, Sundquist J, Sundquist K. Risk of cancer following hospitalization for type 2 diabetes. Oncologist 2010;15(6):548−55.
- 9. Tulinius H, Sigfússon N, Sigvaldason H, Bjarnadóttir K, Tryggvadottir L. Risk factors for malignant diseases: a cohort study on a population of 22,946 Icelanders. Cancer Epidemiol Biomarkers Prev 1997;6(11):863−73.
- 10.Chodick G, Heymann AD, Rosenmann L, Green MS, Flash S, Porath A, et al. Diabetes and risk of incident cancer: a large population-based cohort study in Israel. Cancer Causes Control 2010;21(6):879−87.
- 11.Aschebrook-Kilfoy B, Sabra MM, Brenner A, Moore SC, Ron E, Schatzkin A, et al. Diabetes and thyroid cancer risk in the National Institutes of Health-AARP Diet and Health Study. Thyroid 2011;21(9):957−63.
- 12.Yeo Y, Ma SH, Hwang Y, Horn-Ross PL, Hsing A, Lee KE, et al. Diabetes Mellitus and Risk of Thyroid Cancer: A Meta-Analysis. PLOS ONE 2014;9(6):e98135.
- 13.Li H, Qian J. Association of diabetes mellitus with thyroid cancer risk: A meta-analysis of cohort studies. Medicine(Baltimore) 2017;96(47):e8230.
- 14.Ayturk S, Gursoy A, Kut A, Anil C, Nar A, Tutuncu NB. Metabolic syndrome and its components are associated with increased thyroid volume and nodule prevalence in a mild-to-moderate iodine-deficient area. Eur J Endocrinol 2009;161(4):599−605.
- 15.Rezzonico J, Rezzonico M, Pusiol E, Pitoia F, Niepomniszcze H. Introducing the thyroid gland as another victim of the insulin resistance syndrome. Thyroid 2008;18(4):461−4.
- 16.Zivaljevic V, Slijepcevic N, Paunovic I, Diklic A, Kalezic N, Marinkovic J, et al. Risk Factors for Anaplastic Thyroid Cancer. Int J Endocrinol 2014;2014:6.
- 17.Seo YG, Choi HC, An AR, Park DJ, Park YJ, Lee KE, et al. The Association between Type 2 Diabetes Mellitus and Thyroid Cancer. J Diabetes Res 2017;2017:5850879.
- 18.Ewald DR, Sumner SCJ. Blood Type Biochemistry and Human Disease. Wiley Interdiscip Rev Syst Biol Med 2016;8(6):517−35.
- 19.Akhtar K, Mehdi G, Sherwani R, Sofi L. Relationship between various cancers and ABO blood groups–A Northern India experience. Int J Pathol 2010;13(1):3−7.
- 20.Jin T, Li PJ, Chen XZ, Hu WH. ABO blood group is a predictor of survival in patients with laryngeal cancer. Chin J Cancer 2016;35(1):90.
- 21.Sheng L, Sun X, Zhang L, Su D. ABO blood group and nasopharyngeal carcinoma risk in a population of Southeast China. Int J Cancer 2013;133(4):893−7.
| APA | KHOSHSIRAT S, PEYVANDI A, OROEI M, PEYVANDI H, REZAEIFARD A (2020). The Estimation of Thyroid Cancer Risk based on Type 2 Diabetes Mellitus and ABO Blood Group. , 64 - 69. 10.5505/tjo.2020.2066 |
| Chicago | KHOSHSIRAT Shahrokh,PEYVANDI Ali Asghar,OROEI Mahbobeh,PEYVANDI Hassan,REZAEIFARD Ali The Estimation of Thyroid Cancer Risk based on Type 2 Diabetes Mellitus and ABO Blood Group. (2020): 64 - 69. 10.5505/tjo.2020.2066 |
| MLA | KHOSHSIRAT Shahrokh,PEYVANDI Ali Asghar,OROEI Mahbobeh,PEYVANDI Hassan,REZAEIFARD Ali The Estimation of Thyroid Cancer Risk based on Type 2 Diabetes Mellitus and ABO Blood Group. , 2020, ss.64 - 69. 10.5505/tjo.2020.2066 |
| AMA | KHOSHSIRAT S,PEYVANDI A,OROEI M,PEYVANDI H,REZAEIFARD A The Estimation of Thyroid Cancer Risk based on Type 2 Diabetes Mellitus and ABO Blood Group. . 2020; 64 - 69. 10.5505/tjo.2020.2066 |
| Vancouver | KHOSHSIRAT S,PEYVANDI A,OROEI M,PEYVANDI H,REZAEIFARD A The Estimation of Thyroid Cancer Risk based on Type 2 Diabetes Mellitus and ABO Blood Group. . 2020; 64 - 69. 10.5505/tjo.2020.2066 |
| IEEE | KHOSHSIRAT S,PEYVANDI A,OROEI M,PEYVANDI H,REZAEIFARD A "The Estimation of Thyroid Cancer Risk based on Type 2 Diabetes Mellitus and ABO Blood Group." , ss.64 - 69, 2020. 10.5505/tjo.2020.2066 |
| ISNAD | KHOSHSIRAT, Shahrokh vd. "The Estimation of Thyroid Cancer Risk based on Type 2 Diabetes Mellitus and ABO Blood Group". (2020), 64-69. https://doi.org/10.5505/tjo.2020.2066 |
| APA | KHOSHSIRAT S, PEYVANDI A, OROEI M, PEYVANDI H, REZAEIFARD A (2020). The Estimation of Thyroid Cancer Risk based on Type 2 Diabetes Mellitus and ABO Blood Group. Türk Onkoloji Dergisi, 35(1), 64 - 69. 10.5505/tjo.2020.2066 |
| Chicago | KHOSHSIRAT Shahrokh,PEYVANDI Ali Asghar,OROEI Mahbobeh,PEYVANDI Hassan,REZAEIFARD Ali The Estimation of Thyroid Cancer Risk based on Type 2 Diabetes Mellitus and ABO Blood Group. Türk Onkoloji Dergisi 35, no.1 (2020): 64 - 69. 10.5505/tjo.2020.2066 |
| MLA | KHOSHSIRAT Shahrokh,PEYVANDI Ali Asghar,OROEI Mahbobeh,PEYVANDI Hassan,REZAEIFARD Ali The Estimation of Thyroid Cancer Risk based on Type 2 Diabetes Mellitus and ABO Blood Group. Türk Onkoloji Dergisi, vol.35, no.1, 2020, ss.64 - 69. 10.5505/tjo.2020.2066 |
| AMA | KHOSHSIRAT S,PEYVANDI A,OROEI M,PEYVANDI H,REZAEIFARD A The Estimation of Thyroid Cancer Risk based on Type 2 Diabetes Mellitus and ABO Blood Group. Türk Onkoloji Dergisi. 2020; 35(1): 64 - 69. 10.5505/tjo.2020.2066 |
| Vancouver | KHOSHSIRAT S,PEYVANDI A,OROEI M,PEYVANDI H,REZAEIFARD A The Estimation of Thyroid Cancer Risk based on Type 2 Diabetes Mellitus and ABO Blood Group. Türk Onkoloji Dergisi. 2020; 35(1): 64 - 69. 10.5505/tjo.2020.2066 |
| IEEE | KHOSHSIRAT S,PEYVANDI A,OROEI M,PEYVANDI H,REZAEIFARD A "The Estimation of Thyroid Cancer Risk based on Type 2 Diabetes Mellitus and ABO Blood Group." Türk Onkoloji Dergisi, 35, ss.64 - 69, 2020. 10.5505/tjo.2020.2066 |
| ISNAD | KHOSHSIRAT, Shahrokh vd. "The Estimation of Thyroid Cancer Risk based on Type 2 Diabetes Mellitus and ABO Blood Group". Türk Onkoloji Dergisi 35/1 (2020), 64-69. https://doi.org/10.5505/tjo.2020.2066 |
